Matching-Adjusted Indirect Comparison of the Efficacy of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis Beyond Week 16. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s319. https://doi.org/10.25251/skin.8.supp.319